USPTO serial 79412331
APOLLOX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 21, 2025
- Examiner
- NOLASCO-ARIAS, KENNETH E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with APOLLOX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Fujifilm Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by Fujifilm Diosynth Biotechnologies UK Limited
Fujifilm Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by Fujifilm Diosynth Biotechnologies UK Limited
Fujifilm Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by Fujifilm Diosynth Biotechnologies UK Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Allisen Pawlenty
Allisen Pawlenty Coates IP3057 Nutley St. #801Fairfax, VA 22031United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Cell cultures used in industry and science; mammalian cell cultures and vectors, being independent replicating pieces of DNA that can transfer DNA sequences, each for use in industry and science; biological preparations for use in science; biological preparations for use in cell cultures for use in industry and science; cell culture reagents for scientific and research use; media for cell culture for use in industry and science; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes | ACTIVE | — |
| 040 | Processing and manufacturing of vectors, cell cultures and recombinant proteins for use in biotechnology industries to the order and specification of others; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; custom processing and manufacturing services in the field of biopharmaceuticals; custom processing and manufacturing of biological products; custom manufacture of biopharmaceuticals; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid | ACTIVE | — |
| 042 | Scientific research, industrial research in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals and technical product research and development services in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; development and analysis services relating to the use of mammalian cell cultures and vectors in the field of biotechnology; industrial process development in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; development of processes for the use of mammalian cell cultures and vectors in the manufacture of biotechnology products; technical project studies in the field of biomanufacturing, bioprocessing, biopharmaceuticals and pharmaceuticals; project studies relating to the use of mammalian cell cultures and vectors in the field of biotechnology; development of processes for the use in the manufacture of biotechnology products; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; development of processes for use in the manufacture of pharmaceutical and biological products; biopharmaceutical product development; design and development of manufacturing processes in the field of biopharmaceuticals; development of chemicals for use in the manufacture of biotechnology products and pharmaceuticals; preparation of biological samples for analysis in research laboratories; information, advice and consultancy in relation to all the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Fujifilm Diosynth Biotechnologies UK Limited
- Other trademarks owned by Fujifilm Diosynth Biotechnologies UK Limited
- Other trademarks owned by Fujifilm Diosynth Biotechnologies UK Limited
- Other trademarks in Class 001
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named APOLLOX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 21, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 6, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 6, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 21, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 27, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 31, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 10, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 10, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 12, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 12, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 6, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 5, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 23, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |